STOCK TITAN

Crown Equity Hol Financials

CRWE
Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Crown Equity Hol (CRWE) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CRWE FY2025

Tiny revenue and negative equity show a business relying on recurring external funding instead of self-funded operations.

From FY2023 to FY2025, total liabilities fell from $1.48M to $323K. Even after that reset, FY2025 still showed only $8.6K of assets against negative equity of -$314K, so liability reduction did not rebuild a self-supporting operating base or restore much balance-sheet flexibility.

FY2025 generated just $777 of revenue, while interest expense alone was $19.9K. That gap says the business's fixed financial burden is far larger than its current operating scale, so cash needs are driven by legacy obligations more than by day-to-day commerce. Because assets are also minimal, there is little balance-sheet mass to absorb even modest operating volatility.

Operations used -$34.6K of cash in FY2025, and financing brought in $33.0K. Cash generation quality is therefore weak: outside funding mainly replaced operating burn, and year-end cash of $2.3K did not provide much cushion. In effect, financing worked more like a refill hose than growth capital.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 17 / 100
Financial Profile 17/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Crown Equity Hol's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth
100

Crown Equity Hol's revenue declined 46.2% year-over-year, from $1K to $777. This contraction results in a growth score of 100/100.

Leverage
2

Crown Equity Hol has elevated debt relative to equity (D/E of -1.03), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 2/100, reflecting increased financial risk.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$777
YoY-46.2%
5Y CAGR-22.9%
10Y CAGR-8.6%

Crown Equity Hol generated $777 in revenue in fiscal year 2025. This represents a decrease of 46.2% from the prior year.

EBITDA
N/A
Net Income
N/A
EPS (Diluted)
N/A

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$2K
YoY-41.1%
5Y CAGR-5.7%
10Y CAGR-0.7%

Crown Equity Hol held $2K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
16M
YoY+0.6%
5Y CAGR+4.3%
10Y CAGR+3.9%

Crown Equity Hol had 16M shares outstanding in fiscal year 2025. This represents an increase of 0.6% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
N/A

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

CRWE Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $0-100.0% $200-28.3% $279+71.2% $163+20.7% $135-77.9% $612+65.9% $369+129.2% $161
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses N/A N/A $25K+19.1% $21K N/A N/A $11K N/A
Operating Income N/A N/A -$25K-18.7% -$21K N/A N/A N/A N/A
Interest Expense $6K+9.2% $5K+9.0% $5K+4.2% $5K-2.3% $5K+8.9% $4K+6.4% $4K+18.6% $4K
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income N/A N/A N/A -$24K-646.3% -$3K N/A N/A N/A
EPS (Diluted) $0.00 N/A $0.00 $0.00 $0.00 N/A $-0.030.0% $-0.03

CRWE Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $7K-22.2% $9K+49.4% $6K-12.1% $7K+325.5% $2K-60.2% $4K+8.9% $4K+50.0% $2K
Current Assets $7K-22.2% $9K+49.4% $6K-12.1% $7K N/A $4K+8.9% $4K+50.0% $2K
Cash & Equivalents $2K-1.4% $2K-26.5% $3K-52.6% $7K+325.5% $2K-60.2% $4K+30.2% $3K+75.6% $2K
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $366K+13.5% $323K-1.0% $326K+8.9% $299K+8.8% $275K-15.5% $326K+5.5% $309K-4.4% $323K
Current Liabilities N/A N/A N/A N/A N/A N/A $309K-4.4% $323K
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity -$360K-14.5% -$314K+1.9% -$320K-9.4% -$293K-7.1% -$273K+15.0% -$322K-5.4% -$305K+4.8% -$320K
Retained Earnings -$18.8M-0.2% -$18.8M-0.3% -$18.7M-0.2% -$18.7M+0.7% -$18.8M-0.9% -$18.7M-0.1% -$18.6M-2.8% -$18.1M

CRWE Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow -$30K-336.5% -$7K-7.7% -$6K+27.9% -$9K N/A -$5K+51.6% -$10K N/A
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow $0 $0 $0 $0 $0-100.0% $400 $0+100.0% -$499
Financing Cash Flow $30K+394.5% $6K+103.8% $3K-78.4% $14K N/A $5K-52.7% $11K+6.1% $10K
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

CRWE Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A -8817.2%+3893.2pp -12710.4% N/A N/A N/A N/A
Net Margin N/A N/A N/A -14922.1%-12508.0pp -2414.1% N/A N/A N/A
Return on Equity N/A N/A N/A N/A N/A N/A N/A N/A
Return on Assets N/A N/A N/A -372.7%-160.2pp -212.4% N/A N/A N/A
Current Ratio N/A N/A N/A N/A N/A N/A 0.010.0 0.01
Debt-to-Equity -1.020.0 -1.030.0 -1.020.0 -1.02-0.0 -1.010.0 -1.010.0 -1.010.0 -1.01
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Note: Shareholder equity is negative (-$314K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

Frequently Asked Questions

Crown Equity Hol (CRWE) reported $777 in total revenue for fiscal year 2025. This represents a -46.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Crown Equity Hol (CRWE) revenue declined by 46.2% year-over-year, from $1K to $777 in fiscal year 2025.

Crown Equity Hol (CRWE) generated -$35K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Crown Equity Hol (CRWE) had $9K in total assets as of fiscal year 2025, including both current and long-term assets.

Crown Equity Hol (CRWE) had 16M shares outstanding as of fiscal year 2025.

Crown Equity Hol (CRWE) had a debt-to-equity ratio of -1.03 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Based on fiscal year 2025 data, Crown Equity Hol (CRWE) had $2K in cash against an annual operating cash burn of $35K. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Crown Equity Hol (CRWE) has negative shareholder equity of -$314K as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Crown Equity Hol (CRWE) scores 17 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top